Compare Crocs, Inc. (CROX) vs Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crocs, Inc. vs Haleon plc American Depositary Shares (Each representing two Ordinary Shares) — how do they compare? Crocs, Inc. trades at $116.68 (market cap $5.53B), while Haleon plc American Depositary Shares (Each representing two Ordinary Shares) trades at $9.26 (market cap $39.95B). The key difference: Haleon plc American Depositary Shares (Each representing two Ordinary Shares) is far larger — about 7.2× Crocs, Inc.'s market cap, and Haleon plc American Depositary Shares (Each representing two Ordinary Shares) pays a 2.2% dividend while Crocs, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Crocs, Inc. for 96 Days and Haleon plc American Depositary Shares (Each representing two Ordinary Shares) for 0 Days on average.
| CROX | HLN | |
|---|---|---|
Market Cap | $5.53B | $39.95B |
Volume | 967,176 | 18,243,581 |
Sector | Consumer Cyclical | Health |
52-Week High | $141.19 | $11.27 |
52-Week Low | $73.39 | $8.70 |
Typical Hold Time | 96 Days | 0 Days |
Enterprise Value | $7.04B | $49.77B |
Dividend Yield | — | 2.2% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Crocs (CROX) trades at $116.84, down 2.81% today, amid bearish technical signals but strong fundamental valuation metrics. The stock shows attractive P/E of 10.23 and P/S of 1.46, with robust profitability margins including 57.47% gross margin and 42.3% ROE. Recent earnings have consistently beaten expectations, with Q2 2026 EPS of $4.55 surpassing the $4.35 estimate. The company maintains strong cash flow generation despite a net loss in 2025, with management focusing on product innovation and HEYDUDE brand repositioning.
CROX presents a compelling value opportunity with discounted valuation multiples relative to historical performance, though near-term technical weakness and competitive pressures warrant caution. Analyst consensus remains bullish with $136.78 price target representing 17% upside potential. Key risks include consumer discretionary spending sensitivity and execution challenges with brand diversification initiatives. The stock's current levels offer entry points for long-term investors seeking exposure to a profitable footwear company with strong brand recognition.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Crocs, Inc.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company include Americas, Asia pacific, and EMEA.
Read more on CROX →About Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
Haleon is a consumer healthcare company offering over-the-counter medicines, oral health products, vitamins, and wellness brands.
Read more on HLN →
